Plantonin 

  Early Stage Capital  

  

  Newbrook Consulting ltd  

New Zealand law typically requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer, where: a. Investments of $750,000 or more: the amount invested upfront by the investor (plus any other investments the investor has already made in the financial products) is $750,000 or more. Investments of this kind (i.e., $750,000 or more) are not suitable for retail investors; and b. Other wholesale investors: other wholesale investor categories apply to you under Schedule 1 of the Financial Markets Conduct Act 2013. As a result of these exclusions, you may not receive a complete and balanced set of information. You will also have fewer other legal protections for these investments. Ask questions, read all documents carefully, and seek independent financial advice before committing yourself

Overview

The opportunity exists for wholesale investors to express an interest to invest in Plantonin.

Plantonin specialises in the development of scientifically researched high quality nootropics, supplements, and creams for the North American market. Plantonin has internationally protected IP and trademarks allowing scale and sources, where it can, scientifically researched premium New Zealand sustainable ingredients that global consumers trust and that also have a point of difference from others within the market. Following extensive research, Plantonin has developed a range of unique nootropics, supplements, and creams for the North American market. It's unique formulations have been formulated by some of New Zealand’s best biochemists, scientists, naturopaths, and medical herbalists. Currently, Plantonin exports mostly to the North American market selling to 145 million prime customers on the Amazon platform. Sales to date have been promising with strong customer feedback and a pathway to significant growth achievable with the right investment.


The future opportunities are significant with a global market work of $295.5bn being $67bn in the United States alone. The Plantonin executive team have identified other key global markets such as Canada and Asia and work closely with NZTE. Plantonin is seeking capital to scale the business and is offering an opportunity to invest in an exciting global industry, from New Zealand. Plantonin is forecasting to achieve revenues of $9.4M by FTY24 with an EBITDA of $2M just through its current market channels, returning a consistent yield to shareholders.


On offer is the opportunity to invest into Plantonin through ordinary shares priced at $0.78 per share with a minimum investment of $50,000 against a pre-money valuation of $7.8M.

Please review the information memorandum, found in the Documents tab or Register Interest.


Issue Type:
Early Stage Capital
Sector:
Health Care
isEOI: true

Investment Details

Investment Type: Wholesale

Wholesale Investment Type: NZ Wholesale Equities

Transaction Size:NZD 1,500,000.00

Committed Capital: 

Pre-money valuation:NZD 7,800,362.00

Minimum Capital Raise: 

Share Price:NZD 0.00

Unit Price:NZD 0.78

Minimum Investment Size:NZD 50,000.00

Advisor

Newbrook Consulting Limited

Website:

Email: [email protected]

Phone:027 210 7277

Document Name Description Date Uploaded
Newbrook Plantonin IM - Syndex 19 July 2021 Preview/Download
Zoom: 0

You do not have any investments to report on.

No trade history available for this issue.

Secondary Market - Plantonin Wholesale

No secondary market listings for this issue availble at this time. Check the Exchange for more listings.